17 May 2011
Venue: Perrin Lecture Theatre, Whitechapel Campus
Slaying poverty and inequality is the cornerstone of public health. Risk avoidance and consumer demand is the mainstay of business strategies. International commerce plays an increasing role in the provision of welfare across the world. However whereas public health must formulate and design health policies to redistribute resources more fairly; business strategies focus on dismantling these equity mechanisms and replacing them with selective systems in order to gain access to pools of tax finance.
Public health is engaged in a contest to protect risk sharing and universality from an evolving technical apparatus whose aim is to support the new hegemony of market driven health care. In this lecture the influence of commercial interests on the scientific basis and normative direction of policy-making will be discussed to show how the strategic preoccupations of industry have interpenetrated public health sciences research and policy via a new ‘academy’ increasingly dedicated to market selection.
Allyson Pollock is Professor of Public Health Research and Policy. She was professor and director of the Centre for International Public Health Policy at the University of Edinburgh and before that professor and head of the Public Health Policy Unit at UCL and director of research and development at UCL Hospitals NHS Trust. She trained in medicine in Scotland and became a consultant in public health medicine in 1991. Her research interests include globalisation; privatisation, marketisation and PFI / PPPs; pharmaceuticals and clinical trials; and child injuries. She is the author of NHS plc and co-author of The New NHS: a guide.
For a map and directions to this venue click here
To book a place at this event please contact firstname.lastname@example.org